0001179110-20-007591.txt : 20200619
0001179110-20-007591.hdr.sgml : 20200619
20200619080513
ACCESSION NUMBER: 0001179110-20-007591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200618
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KELER TIBOR
CENTRAL INDEX KEY: 0001429931
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 20974293
MAIL ADDRESS:
STREET 1: 30 PARK ROAD
CITY: OTTSVILLE
STATE: PA
ZIP: 18942
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0306
4
2020-06-18
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001429931
KELER TIBOR
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD
HAMPTON
NJ
08827
0
1
0
0
Executive VP & CSO
Incentive Stock Option (right to buy)
10.38
2020-06-18
4
A
0
108000
0.00
A
2021-06-18
2030-06-18
Common Stock
108000
108000
D
Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
/s/ Samuel B. Martin, attorney in fact for Tibor Keler
2020-06-19